UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch
Phase NA Completed
219 enrolled
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Phase 2 Completed
2 enrolled 8 charts
Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
Phase 1 Completed
32 enrolled
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract
Phase 2 Completed
53 enrolled
Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Phase 2 Completed
40 enrolled 7 charts
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
Phase 2 Completed
34 enrolled 9 charts
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
Phase NA Completed
200 enrolled
VINGEM
Phase 2 Completed
62 enrolled
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Phase 1 Completed
10 enrolled 14 charts
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Phase 2 Completed
82 enrolled
VINSOR
Phase 1 Completed
22 enrolled
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)
Phase 2 Completed
63 enrolled
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Completed
5 enrolled
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Phase 1/2 Completed
15 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium
Phase 2 Completed
78 enrolled 6 charts
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium
Phase 1 Completed
33 enrolled
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Phase NA Completed
29 enrolled
Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
Phase 2 Completed
40 enrolled
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Phase 2 Completed
65 enrolled
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled